BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18484429)

  • 1. Atypical fibroxanthoma presenting in a patient with stage III mycosis fungoides.
    Avshalumov K; Williford P; Sangueza OP; Goldenberg G
    J Dermatolog Treat; 2008; 19(2):118-20. PubMed ID: 18484429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent atypical fibroxanthoma of the cheek.
    Skoulas IG; Price M; Andrew JE; Kountakis SE
    Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichilemmal cyst with carcinoma in situ within an atypical fibroxanthoma.
    Arsenovic N; Sen S; Naik V; Reed M; Moreira R
    Am J Dermatopathol; 2009 Aug; 31(6):587-90. PubMed ID: 19590414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosis fungoides exhibiting features of a dermatofibroma: a case report and review of the literature.
    Morcos SM; Girardi M; Subtil A; Wilson LD; Cowper SE
    J Cutan Pathol; 2012 Jan; 39(1):40-6. PubMed ID: 22059953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granular cell atypical fibroxanthoma.
    Rudisaile SN; Hurt MA; Santa Cruz DJ
    J Cutan Pathol; 2005 Apr; 32(4):314-7. PubMed ID: 15769283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual presentation of atypical fibroxanthoma.
    Vandergriff TW; Reed JA; Orengo IF
    Dermatol Online J; 2008 Jan; 14(1):6. PubMed ID: 18319023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
    Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
    Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis.
    Belousova IE; Vanecek T; Samtsov AV; Michal M; Kazakov DV
    J Am Acad Dermatol; 2008 Sep; 59(3):474-82. PubMed ID: 18694680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
    Ly H; Selva D; James CL; Huilgol SC
    Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell atypical fibroxanthoma - report of a case with review of the literature.
    Murali R; Palfreeman S
    J Cutan Pathol; 2006 May; 33(5):343-8. PubMed ID: 16640540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
    Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
    Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
    Kram A; Stańczyk J; Woyke S
    Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical fibroxanthoma of the scalp following hair transplantation in a 35-year-old male.
    Gil T; Sabo E; Kerner H; Metanes I; Har-Shai Y
    J Plast Reconstr Aesthet Surg; 2010 Oct; 63(10):e725-8. PubMed ID: 20673656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasizing fibrous histiocytoma of the skin: a clinicopathologic and immunohistochemical analysis of three cases.
    Guillou L; Gebhard S; Salmeron M; Coindre JM
    Mod Pathol; 2000 Jun; 13(6):654-60. PubMed ID: 10874670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?
    Ang GC; Roenigk RK; Otley CC; Kim Phillips P; Weaver AL
    Dermatol Surg; 2009 May; 35(5):765-72. PubMed ID: 19389106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell atypical fibroxanthoma:a clinicopathologic study.
    Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
    J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxoid atypical fibroxanthoma: a previously undescribed variant.
    Patton A; Page R; Googe PB; King R
    J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myofibroblastic differentiation in atypical fibroxanthomas occurring on sun-exposed skin and in a burn scar: an ultrastructural and immunohistochemical study.
    Ito A; Yamada N; Yoshida Y; Morino S; Yamamoto O
    J Cutan Pathol; 2011 Aug; 38(8):670-6. PubMed ID: 21623865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.